
Pharmacogenomics enhances cardiometabolic disease management by personalizing medication based on genetic profiles, empowering pharmacists to optimize patient care.

Pharmacogenomics enhances cardiometabolic disease management by personalizing medication based on genetic profiles, empowering pharmacists to optimize patient care.

Independent pharmacies navigate a transformative 2026, benefiting from increased PBM accountability and transparency, fostering a more stable operational landscape.

Inhaled Technosphere insulin revolutionizes diabetes management for children and pregnant women, addressing treatment adherence and psychological barriers effectively.

As lawmakers continue to deliberate on HR 7148, pharmacy law expert, Jesse Dresser, Esq, joined Drug Topics to discuss its provisions related to PBMs.

Pharmacists play a crucial role in managing complex medication regimens, ensuring safety and effectiveness for patients with behavioral health conditions.

Jari Becker, RPh, director of women’s health at Town & Country Compounding Pharmacy in Ramsey, New Jersey, shares how the pharmacy creates customized medications for patients all over the US.

Pharmacists enhance community health by providing vital services such as vaccinations and chronic disease management, despite facing reimbursement and recognition challenges.

Despite a significant leap in the development of asthma therapies, depression symptoms continue to be a roadblock for improved outcomes.

Pharmacists play a crucial role in managing polypharmacy, enhancing patient care through medication reconciliation and personalized therapy strategies.

A plant-based lifestyle intervention can lead to diabetes remission and weight loss, transforming traditional diabetes management strategies.

If signed by President Trump in time to avoid a government shutdown, HR 7148 has potential to enforce significant change in the prescription drug supply chain.

Pharmacists transform health care by offering essential services, tackling the opioid crisis, and adapting to new initiatives for better patient outcomes.

With a multitude of concerns surrounding corticosteroids for asthma, researchers explore the overall clinical and economic burden of these drugs.

High-dose vitamin D3 shows promise in improving metabolic health for type 2 diabetes patients, enhancing glycemic control alongside traditional treatments.

By uncovering insights on the regulatory framework regarding Rx-to-OTC rejections, researchers aim to address key challenges and concerns impeding self-care management.

This episode explores important insights on PBM reform and what pharmacies can look out for throughout 2026.

A recent survey reveals that over half of US patients face challenges with prescription costs, highlighting the need for better cost transparency and support.

Pharmacists enhance travel medicine by offering tailored consultations, risk assessments, and vaccine management, ensuring safe international travel for patients.

As more prescription drugs move to OTC, the pharmacist’s role in their communities are continuing to shift as well.

As pharmacists continue to take on greater clinical roles, the growing need to address mental health concerns is reaching a boiling point.

The American Academy of Pediatrics responds to recent HHS vaccine guideline changes with its own schedule for childhood and adolescent patients.

In part 2, Alyssa Billingsley, PharmD, explores some of the recent switches that made waves in the US and how they impact pharmacy operations as well as patient outcomes.

Consultant pharmacists enhance vaccination efforts in long-term care, addressing challenges like vaccine fatigue while advocating for age-friendly care and improved patient outcomes.

With 15 more drugs’ negotiations announced and 1 drug being renegotiated, new prices are set to take effect at the start of 2028.

Community pharmacies continue to operate in unchartered territory regarding Medicare drug price negotiations as the new IRA statute becomes an unavoidable reality for business operations.

As respiratory virus season approaches, misinformation threatens lives; understanding vaccines is crucial for protecting our communities and future.

As various regions across the country experience snowstorms, pharmacies must be proactive about ensuring minimal disruptions to their operations.

Alyssa Billingsley, PharmD, discusses the FDA’s prescription to over-the-counter drug development process and what it means for patients and pharmacies.

The Pharmacy Quality Alliance enhances patient outcomes by addressing social determinants of health through effective community partnerships and pharmacist involvement.

During the week of Roe v Wade’s 53rd anniversary, debates between pro-choice and pro-life groups are yet again reaching the national stage.